Drug Approvals
🇺🇸 FDA Page 47FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 553–564 of 665 articles
COFEPRIS Approval Trends 2026: Fast-Track & Generics Impact in Mexico
SFDA Accelerated Approval Pathway: Enhancing Oncology Drug Access in Saudi Arabia
FDA Approval of Elarekibart: Current Status and Market Implications
LENZ Therapeutics Submits VIZZ Presbyopia Treatment for UK Approval Following EU Validation
Verismo Therapeutics SynKIR-110 Shows Promising Safety Profile in Phase 1 STAR-101 Trial for Advanced Solid Tumors
FDA Grants Priority Review to PADCEV-Keytruda Combination for Muscle-Invasive Bladder Cancer Treatment
FDA Approves DermaClear: New Safe Option for Severe Acne Vulgaris
FDA Approves First Cell Therapy for Treatment-Resistant MS
SAHPRA Accelerated Review Program: One Year Assessment & Oncology Approval Trends
SAHPRA HIV treatment approval: Lenacapavir's Role in Epidemic Control
SAHPRA Approval of Lenacapavir: A New Era in HIV Prevention in South Africa
Breakthrough Therapy Designations Drive Neurological Drug Innovation in US